What is Regeneron Pharmaceuticals's change in AP?

Regeneron Pharmaceuticals (REGN) reported change in AP of $107.7M in Q1 2026.

How has Regeneron Pharmaceuticals's change in AP changed year-over-year?

Regeneron Pharmaceuticals's change in AP increased by 150.3% year-over-year, from -$214.1M to $107.7M.

What is the long-term trend for Regeneron Pharmaceuticals's change in AP?

Over 2 years (2021 to 2025), Regeneron Pharmaceuticals's change in AP has grown at a -6.2% compound annual growth rate (CAGR), from $866.1M to $761.5M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Regeneron Pharmaceuticals REGN Change in AP

Change in AP at other companies

Merck & Co.MRK

$27.5M-39.6%

AmgenAMGN

$571M+14.9%

Nektar TherapeuticsNKTR

-$934K-115%

GlaukosGKOS

-$10.19M-51.5%

Ocular TherapeutixOCUL

$3.72M+53,029%

Kodiak Sciences IncKOD

-$733K-128%

Other financials

Income statement

See full

Revenue$3.6B+19.0%

Operating income$642.9M+8.7%

Net income$727.2M-10.1%

EPS (diluted)$6.75-7.2%

Balance sheet

See full

Cash & equivalents$3.0B-4.0%

Total debt$2.7B+0.1%

Total equity$31.4B+6.9%

Total assets$40.9B+8.9%

Cash flow

See full

Operating cash flow$1.1B+3.2%

CapEx$230.6M+0.6%

Free cash flow$848.3M+4.0%

Valuation

See full

Market cap$65.37B+16.2%

Enterprise value$65.11B+14.3%

P/E14.8×+2.2×

P/S4.4×+0.4×

Profitability

See full

Gross margin93.9%—

Operating margin24.3%-2.9pp

Net margin29.6%-2.3pp

FCF margin27.6%+5.5pp

Returns & leverage

See full

Return on equity14.5%-1.4pp

Debt / equity0.1×0.0×

Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regeneron Pharmaceuticals's change in AP?: Regeneron Pharmaceuticals (REGN) reported change in AP of $107.7M in Q1 2026.
How has Regeneron Pharmaceuticals's change in AP changed year-over-year?: Regeneron Pharmaceuticals's change in AP increased by 150.3% year-over-year, from -$214.1M to $107.7M.
What is the long-term trend for Regeneron Pharmaceuticals's change in AP?: Over 2 years (2021 to 2025), Regeneron Pharmaceuticals's change in AP has grown at a -6.2% compound annual growth rate (CAGR), from $866.1M to $761.5M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.